Melanoma trials in Netherlands
43 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleACTME
- Where
- Leiden
- Age
- 18 years and over
- People
- 58
- Run by
- Leids Universitair Medisch Centrum (LUMC)
See details and how to join2024-516125-31-02 · EU 2024-516125-31-02 - No phaseTaking peopleOmitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node
- Where
- Rotterdam
- Age
- 16 years and over
- People
- 213
- Run by
- D.J. (Dirk) Grünhagen
See details and how to joinNCT06754904 - Phase 3Taking peopleSafe Stop Trial Melanoma
- Where
- Amsterdam, Breda, Eindhoven, Enschede, Groningen, Heerlen, Leeuwarden, Leiden, Maastricht, Nijmegen, Rotterdam, Utrecht, Zwolle
- Age
- 18 years and over
- People
- 200
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2024-516937-10-01 · EU 2024-516937-10-01 - Phase 4Taking peopleCO2MO
- Where
- Leiden, Zwolle
- Age
- 18 years and over
- People
- 96
- Run by
- Leids Universitair Medisch Centrum (LUMC)
See details and how to join2025-520913-29-00 · EU 2025-520913-29-00 - No phaseTaking peopleEvaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma
- Where
- Dordrecht, Rotterdam
- Age
- 18 years and over
- People
- 180
- Run by
- Erasmus Medical Center
See details and how to joinNCT06643286 - Phase 2Taking peopleOpen Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors
- Where
- Groningen
- Age
- 18 years and over
- People
- 97
- Run by
- University Medical Center Groningen
See details and how to joinNCT05483400 · EU 2024-512616-21-00 - Phase 1/2Taking peopleFMT to Convert Response to Immunotherapy
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 24
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT05251389 - No phaseTaking peopleSafe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 80
- Run by
- Erasmus Medical Center
See details and how to joinNCT05652673 - Phase 4Not yet taking people in NetherlandsStatins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 140
- Run by
- Erasmus Medical Center
See details and how to joinNCT06785974 - No phaseTaking peopleEMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial
- Where
- Leiden
- Age
- 18 years and over
- People
- 30
- Run by
- Leiden University Medical Center
See details and how to joinNCT06767332 - Phase 2/3Taking peopleContrast-enhanced ultrasound for sentinel node detection in patients with melanoma, breast cancer or head & neck cancer
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 91
- Run by
- Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
See details and how to join2024-515259-40-00 · EU 2024-515259-40-00 - No phaseTaking peopleMelanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- Where
- Almere Stad, Ede, Eindhoven, Groningen, Heerlen, Maastricht, Utrecht, Veldhoven, Zutphen, Zwolle
- Age
- 18 years and over
- People
- 2,998 worldwide
- Run by
- Melanoma and Skin Cancer Trials Limited
See details and how to joinNCT03860883 - Phase 1/2Taking peopleIntradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma
- Where
- Amsterdam, Groningen, Leiden, Rotterdam, Utrecht
- Age
- 18 years and over
- People
- 96 worldwide
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT06240143 · EU 2023-505945-19-00 - No phaseTaking peopleThe 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology
- Where
- Leiden
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- Leiden University Medical Center
See details and how to joinNCT06685562 - Phase 4Taking peopleNivolumab dose optimization in patients with a complete, partial or stable response (NIVOPTIMIZE-trial)
- Where
- Rotterdam, Zwolle
- Age
- 18 years and over
- People
- 34
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to joinNCT06116461 · EU 2024-516718-39-00 - Phase 1/2Taking peopleEvaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion
- Where
- Amsterdam, Rotterdam
- Age
- 18 years and over
- People
- 74 worldwide
- Run by
- Vastra Gotaland Region
See details and how to joinNCT03685890 · EU 2023-509265-21-00 - Phase 1/2Taking peopleMAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 20
- Run by
- Erasmus Medical Center
See details and how to joinNCT04729543 · EU 2024-516922-70-00 - Phase 2Taking peopleA Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 214
- Run by
- A.J.M. van den Eertwegh
See details and how to joinNCT04126876